Relevance tier by entity

Entity Tier Description
PMBL 2 Role of WDR87 mutations in PMBL requires confirmation

Mutation incidence in large patient cohorts (GAMBL reanalysis)

Entity source frequency (%)
BL GAMBL Exome 4.598
BL GAMBL Genome 2.317
DLBCL GAMBL Exome 3.935
DLBCL GAMBL Genome 3.195
FL GAMBL Exome 0.287

Failed to render page: conflicting chdir during another chdir block

References

1.
Duns G, Viganò E, Ennishi D, Sarkozy C, Hung SS, Chavez E, Takata K, Rushton C, Jiang A, Ben-Neriah S, Woolcock BW, Slack GW, Hsi ED, Craig JW, Hilton LK, Shah SP, Farinha P, Mottok A, Gascoyne RD, Morin RD, Savage KJ, Scott DW, Steidl C. Characterization of DLBCL with a PMBL gene expression signature. Blood. 2021 Jul 15;138(2):136–148.